Abstract
Real-world data (RWD) has become an important source of evidence to support payer decision-making during health technology assessment (HTA). RWD is increasingly reviewed by HTA bodies as supporting evidence for effectiveness and safety of interventions. The aim is to identify and describe the extent published RWD evidence is being reviewed as part of systematic literature reviews (SLRs) for HTA.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
